Advanced Medical Solutions (GB:AMS) has released an update.
Advanced Medical Solutions Group plc (AMS) has announced that as of May 31, 2024, their issued share capital comprises 217,508,089 ordinary shares with voting rights, a key figure for shareholders to determine notification requirements for their interest changes as per the FCA’s Disclosure and Transparency Rules. AMS, a world-leading developer and manufacturer of innovative tissue-healing technology, has a broad product portfolio marketed under various brands, and operates globally with a network of partners and direct sales forces. With a focus on quality outcomes for patients and value for payers, the company has made six acquisitions since 2019, expanding its technological and geographical footprint.
For further insights into GB:AMS stock, check out TipRanks’ Stock Analysis page.
